Results 141 to 150 of about 22,252 (260)

A Prospective Surveillance Study of Candidaemia : Epidemiology, Risk Factors, Antifungal Treatment and Outcome in Hospitalized Patients [PDF]

open access: yes, 2016
Funding This work was supported by the Wellcome Trust Strategic Award for Medical Mycology and Fungal Immunology 097377/Z/11/Z. Data collection was supported by a grant from Pfizer.
Deshpande, Ashutosh   +8 more
core   +2 more sources

Efficacy of caspofungin dose escalation against Candida albicans and Candida glabrata clinical isolates [PDF]

open access: yes, 2016
Munkánk során meghatároztuk a caspofungin által kifejtett ölési rátát RPMI-1640-ben, valamint 50% humán szérummal kiegészített tápközegben C. albicans és C. glabrata klinikai izolátumok ellen.
Domán, Marianna
core  

Aspergillus fumigatus-Related Species in Clinical Practice. [PDF]

open access: yes, 2016
Aspergillus fumigatus is the main etiologic agent of invasive aspergillosis (IA). Other Aspergillus species belonging to the section Fumigati (A. fumigatus complex) may occasionally be the cause of IA.
Lamoth, F.
core   +3 more sources

Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America [PDF]

open access: yes, 2017
Guidelines for the management of patients with invasive candidiasis and mucosal candidiasis were prepared by an Expert Panel of the Infectious Diseases Society of America.
Andes, David   +13 more
core  

Clinical Features, Outcomes, and Antifungal Susceptibility Profiles of Invasive Candida Infections in a Tertiary Care Hospital in China

open access: yesInfection and Drug Resistance
Dongting Yao,1,2,* Jia Chen,3,* Guanyi Zhang3 1Department of Laboratory Medicine, The International Peace Maternity and Child Health Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200030, People’s Republic of China;
Yao D, Chen J, Zhang G
doaj  

In Vitro Activity of Rezafungin Against Planktonic and Biofilm Forms of Candida albicans and Nakaseomyces glabratus Clinical Isolates from Vascular Infections in Poland: A Pilot Study

open access: yesPharmaceutics
Background/Objectives: Certain yeast species are recognized as significant opportunistic pathogens, capable of causing severe systemic infections, particularly in immunocompromised individuals or those with disrupted physiological barriers.
Iwona Skiba-Kurek   +6 more
doaj   +1 more source

Antifungal Susceptibility of Clinical Meyerozyma guillermondii Isolates Obtained Between 1994 and 2014: Original Research and Comparison with Published Data

open access: yesPathogens
(1) Background: Meyerozyma guilliermondii is a yeast species widely distributed in the natural environment and one of the rare emerging pathogens capable of causing difficult to treat, severe infections.
Aleksandra Górzyńska   +5 more
doaj   +1 more source

Multidistrict invasive Candida glabrata infection successfully treated with echinocandin and liposomal amphotericin B combination therapy: a case report and therapeutic perspective

open access: yesFrontiers in Medicine
IntroductionCandida glabrata is the second leading cause of invasive candidiasis worldwide and represents a major clinical challenge due to its intrinsic antifungal resistance, stress tolerance, and ability to persist in hostile host environments.
Massimo Caracciolo   +11 more
doaj   +1 more source

Impact of Obesity on Echinocandin Effectiveness in Treating Candida Infections: A Retrospective Observational Cohort Study

open access: yesInfection and Drug Resistance
Ahmad Aljohani,1,2,* Saeed Alqahtani3,* 1Pharmaceutical Care Services, King Fahd General Hospital, Ministry of Health, Jeddah, Saudi Arabia; 2Department of Pharmacy, College of Pharmacy, Nursing and Medical Sciences, Riyadh Elm University, Riyadh,
Aljohani A, Alqahtani S
doaj  

Effect of caspofungin and micafungin in combination with farnesol against Candida parapsilosis biofilms [PDF]

open access: yes, 2019
Bozó, Aliz   +7 more
core   +1 more source

Home - About - Disclaimer - Privacy